Our Bones Impact Insulin Sensitivity

Most people think of the skeleton as structure. Bones hold us upright, protect organs, give muscles leverage, and allow us to move through the world. In that sense, the skeleton is usually imagined as a kind of living scaffolding.

But research has shown that the skeleton may be far more active than that.

In 2007, groundbreaking research published in Cell revealed that the skeleton, through the vitamin K2-dependent protein osteocalcin, has a significant impact on the body’s production of insulin and sensitivity to insulin. This finding changed the way scientists understood bone. Instead of seeing the skeleton as inert support tissue, the research suggested that bone also functions as a dynamic endocrine organ.

That is a major shift.

An endocrine organ produces signaling molecules that influence other systems in the body. We usually think of endocrine function in relation to glands such as the thyroid, pancreas, adrenals, or reproductive organs. But this research suggested that bone also communicates with metabolism.

The key player is osteocalcin, a protein produced within bone. Osteocalcin is vitamin K2-dependent, meaning vitamin K2 plays an important role in its function. According to the researchers, osteocalcin has the capacity to improve glucose tolerance and influence insulin production and insulin sensitivity.

That matters because insulin resistance is one of the defining features of type 2 diabetes. When the body becomes resistant to insulin, glucose regulation becomes impaired. Blood sugar stays elevated more easily, the pancreas has to work harder, and metabolic dysfunction begins to develop over time.

If bone-derived osteocalcin helps regulate insulin production and sensitivity, then bone health is not only about fractures, posture, or density. It is also connected to metabolic health.

This makes vitamin K2 important in a way many people do not fully appreciate. Vitamin K2 is often discussed in relation to calcium metabolism and bone health, but its relationship with osteocalcin connects it to a much larger conversation. If osteocalcin influences glucose tolerance and insulin sensitivity, then supporting vitamin K2 status may be relevant to the prevention of insulin-resistant diabetes.

The larger point is that the body is not a collection of disconnected parts. Bone affects metabolism. Nutrients affect hormones. Hormones affect blood sugar. The skeleton communicates with the pancreas, energy regulation, and glucose handling.

This is why reductionist thinking often fails in health. When we think of bones only as structure, we miss their role in signaling. When we think of insulin resistance only as a blood sugar problem, we may miss the other tissues and nutrients involved in metabolic regulation.

The 2007 discovery made a strong case that the skeleton should be understood as part of the endocrine system. Bone is not just something the body carries around. It is metabolically active tissue that participates in whole-body regulation.

Our bones do more than hold us up. They help communicate with the systems that determine how well we produce insulin, respond to insulin, and manage glucose.

That means bone health and metabolic health are more connected than most people realize.

---

Reference

Lee, N. K., Sowa, H., Hinoi, E., et al. “Endocrine Regulation of Energy Metabolism by the Skeleton.” Cell 130, no. 3, 2007, 456–469. https://doi.org/10.1016/j.cell.2007.05.047